Skip to main content
. 2013 Feb 3;2013:315170. doi: 10.1155/2013/315170

Figure 5.

Figure 5

Kaplan-Meier survival estimates of patients treated with and without actinomycin. Actinomycin is associated with a 74% reduced risk of death (P = 0.0059) which held true for all age groups.